Combining a long lifespan in vitro with a stable tenogenic phenotype, the Ink4a/Arf−/− tenocyte cell line will enable more extended experiments and significantly facilitate research into the highly prevalent, disabling tendon diseases. Here, CDKN2A is linked to disease of the tendon.